Skip to main content
PMC home page
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 2005 Mar;31(3):144–148. doi: 10.1136/jme.2004.007229

Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report

O Corrigan 1
PMCID: PMC1734105  PMID: 15738433

Abstract

In September this year the Nuffield Council on Bioethics held a meeting to disclose and discuss the main findings of their newly published report on the ethical issues associated with developments in pharmacogenetics research. The basics of pharmacogenetics science is briefly outlined, and then the extent to which the report was successful in addressing (or at least highlighting) the attendant social, ethical, and policy implications of pharmacogenetics research is evaluated.

Full Text

The Full Text of this article is available as a PDF (74.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkin P. A., Shenfield G. M. Medication-related adverse reactions and the elderly: a literature review. Adverse Drug React Toxicol Rev. 1995 Autumn;14(3):175–191. [PubMed] [Google Scholar]
  2. Buchanan Allen, Califano Andrea, Kahn Jeffrey, McPherson Elizabeth, Robertson John, Brody Baruch. Pharmacogenetics: ethical issues and policy options. Kennedy Inst Ethics J. 2002 Mar;12(1):1–15. doi: 10.1353/ken.2002.0001. [DOI] [PubMed] [Google Scholar]
  3. Cassileth B. R., Zupkis R. V., Sutton-Smith K., March V. Informed consent -- why are its goals imperfectly realized? N Engl J Med. 1980 Apr 17;302(16):896–900. doi: 10.1056/NEJM198004173021605. [DOI] [PubMed] [Google Scholar]
  4. Danzon Patricia, Towse Adrian. The economics of gene therapy and of pharmacogenetics. Value Health. 2002 Jan-Feb;5(1):5–13. doi: 10.1046/j.1524-4733.2002.51081.x. [DOI] [PubMed] [Google Scholar]
  5. Dawkins K., Rudorfer M. V., Potter W. Z. Comments on gender differences in pharmacokinetics and pharmacodynamics. Am J Psychiatry. 1993 Apr;150(4):678–679. doi: 10.1176/ajp.150.4.aj1504678. [DOI] [PubMed] [Google Scholar]
  6. Delaney B. C. Dyspepsia management in the millennium: to test and treat or not? Gut. 2003 Jan;52(1):10–11. doi: 10.1136/gut.52.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Freund Carol L., Wilfond Benjamin S. Emerging ethical issues in pharmacogenomics: from research to clinical practice. Am J Pharmacogenomics. 2002;2(4):273–281. doi: 10.2165/00129785-200202040-00007. [DOI] [PubMed] [Google Scholar]
  8. Gage Brian F., Eby Charles, Milligan Paul E., Banet Gerald A., Duncan Jill R., McLeod Howard L. Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. Thromb Haemost. 2004 Jan;91(1):87–94. doi: 10.1160/TH03-06-0379. [DOI] [PubMed] [Google Scholar]
  9. Hedgecoe Adam, Martin Paul. The drugs don't work: expectations and the shaping of pharmacogenetics. Soc Stud Sci. 2003 Jun;33(3):327–364. doi: 10.1177/03063127030333002. [DOI] [PubMed] [Google Scholar]
  10. Issa A. M. Ethical considerations in clinical pharmacogenomics research. Trends Pharmacol Sci. 2000 Jul;21(7):247–249. doi: 10.1016/s0165-6147(00)01493-0. [DOI] [PubMed] [Google Scholar]
  11. Johnson J. A. Drug target pharmacogenomics: an overview. Am J Pharmacogenomics. 2001;1(4):271–281. doi: 10.2165/00129785-200101040-00004. [DOI] [PubMed] [Google Scholar]
  12. Lavori Philip W., Krause-Steinrauf Heidi, Brophy Mary, Buxbaum Joel, Cockroft Jennifer, Cox David R., Fiore Louis, Greely Henry T., Greenberg Harry, Holmes Edward W. Principles, organization, and operation of a DNA bank for clinical trials: a Department of Veterans Affairs cooperative study. Control Clin Trials. 2002 Jun;23(3):222–239. doi: 10.1016/s0197-2456(02)00193-9. [DOI] [PubMed] [Google Scholar]
  13. Lazarou J., Pomeranz B. H., Corey P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998 Apr 15;279(15):1200–1205. doi: 10.1001/jama.279.15.1200. [DOI] [PubMed] [Google Scholar]
  14. Marks Adam D., Steinberg Karen K. The ethics of access to online genetic databases: private or public? Am J Pharmacogenomics. 2002;2(3):207–212. doi: 10.2165/00129785-200202030-00006. [DOI] [PubMed] [Google Scholar]
  15. Moldrup Claus. Ethical, social and legal implications of pharmacogenomics: a critical review. Community Genet. 2001;4(4):204–214. doi: 10.1159/000064194. [DOI] [PubMed] [Google Scholar]
  16. Pirmohamed M., Breckenridge A. M., Kitteringham N. R., Park B. K. Adverse drug reactions. BMJ. 1998 Apr 25;316(7140):1295–1298. doi: 10.1136/bmj.316.7140.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pirmohamed Munir, James Sally, Meakin Shaun, Green Chris, Scott Andrew K., Walley Thomas J., Farrar Keith, Park B. Kevin, Breckenridge Alasdair M. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004 Jul 3;329(7456):15–19. doi: 10.1136/bmj.329.7456.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Roses A. D. Pharmacogenetics and future drug development and delivery. Lancet. 2000 Apr 15;355(9212):1358–1361. doi: 10.1016/S0140-6736(00)02126-7. [DOI] [PubMed] [Google Scholar]
  19. Roses A. D. Pharmacogenetics and the practice of medicine. Nature. 2000 Jun 15;405(6788):857–865. doi: 10.1038/35015728. [DOI] [PubMed] [Google Scholar]
  20. Roses A. D. The human medicine project has started: place your bets now. Drug Discov Today. 2001 Mar 1;6(6):282–284. doi: 10.1016/s1359-6446(01)01722-6. [DOI] [PubMed] [Google Scholar]
  21. Roses Allen D. Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Drug Discov. 2002 Jul;1(7):541–549. doi: 10.1038/nrd840. [DOI] [PubMed] [Google Scholar]
  22. Snowdon C., Garcia J., Elbourne D. Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med. 1997 Nov;45(9):1337–1355. doi: 10.1016/s0277-9536(97)00063-4. [DOI] [PubMed] [Google Scholar]
  23. Williams-Jones Bryn, Corrigan Oonagh P. Rhetoric and hype: where's the 'ethics' in pharmacogenomics? Am J Pharmacogenomics. 2003;3(6):375–383. doi: 10.2165/00129785-200303060-00004. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES